Celnalid 5mg Price UAE | Ernest Oncology International Distributor

Celnalid 5mg Capsule: Advanced Immunomodulatory Therapy for Multiple Myeloma and MDS

Are you searching for a reliable Celnalid 5 mg capsule exporter from India? Ernest Oncology, a premier division of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of specialized hematology treatments. We provide a robust supply chain to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring high-quality oncology medications reach healthcare providers and specialized pharmacies with efficiency and regulatory compliance.

Detailed Product Overview: What is Celnalid 5mg?

Celnalid 5 mg is an oral antineoplastic medication containing the active ingredient Lenalidomide. It belongs to a potent class of drugs known as Immunomodulatory Imides (IMiDs). Lenalidomide is a derivative of thalidomide but has been chemically engineered to be more potent and have a more favorable side-effect profile for the treatment of various blood-related cancers.

The 5mg strength is a crucial component of clinical oncology, often used in maintenance therapy phases, dose-titration protocols for elderly patients, or as part of combination regimens to minimize toxicity while maintaining therapeutic efficacy.

Primary Therapeutic Indications:

Celnalid 5 mg is clinically indicated for several complex conditions:

• Multiple Myeloma (MM): Used in combination with dexamethasone in patients who have received at least one prior therapy or as maintenance therapy following autologous stem cell transplantation.

• Myelodysplastic Syndromes (MDS): Specifically for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

• Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.

• Follicular Lymphoma & Marginal Zone Lymphoma: Often used in combination with rituximab.

Mechanism of Action: How Celnalid 5 mg Works:

Celnalid exerts its anti-cancer effects through a multi-pathway approach:

1. Direct Anti-Tumor Activity: It induces cell cycle arrest and apoptosis (programmed cell death) in malignant hematopoietic cells by inhibiting essential growth signals.

2. Anti-Angiogenesis: It prevents the growth of new blood vessels that tumors need to grow and spread, essentially "starving" the cancer cells.

3. Immunomodulation: It stimulates the patient’s own immune system, specifically increasing the number and activity of Natural Killer (NK) cells and T-cells to better identify and destroy cancer cells

4. Microenvironment Alteration: It disrupts the support system within the bone marrow that myeloma cells rely on to survive.

Administration and Dosage:

• Route: Administered orally (capsules).

• Dosage: The dosage is highly individualized based on the patient's condition, renal function, and blood counts. Capsules should be taken at approximately the same time each day.

• Instructions: Capsules must be swallowed whole with water and should not be opened, broken, or chewed.

Safety Profile & Side Effects:

Healthcare professionals must monitor patients for the following:

• Embryo-Fetal Toxicity: Lenalidomide is structurally related to thalidomide; strict pregnancy prevention programs (REMS) are required.

• Hematologic Toxicity: Monitoring for Neutropenia (low white blood cells) and Thrombocytopenia (low platelets) is vital.

• Venous Thromboembolism: Increased risk of blood clots; prophylactic anticoagulation is often recommended.

• Common Side Effects: Fatigue, diarrhea, nausea, and skin rashes.

Why source Celnalid 5 mg from Ernest Oncology?

• Verified Supply Chain: Direct procurement from GMP-certified facilities, ensuring 100% authenticity for every exporter from India shipment.

• Global Logistics Expertise: Professional handling of international regulatory documentation for the USA, UK, UAE, Australia, and South Africa. 

• Bulk Supply Stability: We maintain a consistent inventory of 5mg, 10mg, 15mg, and 25mg strengths to prevent treatment interruptions.

• B2B Partnership Focus: Specialized pricing and track-and-trace logistics for international pharmaceutical distributors and oncology centers.